StockClub

AQSZF

AQSZFAequus Pharmaceuticals Inc.$ --
Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals Inc.

AQSZF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2025FY2025 Q3
Revenue
0M CAD
YoY +69.7%
Operating Income
-0M CAD
YoY +84.0%
Net Income
0M CAD
YoY +160.3%
EPS
0CAD
YoY +160.9%

Revenue

CAD696,519
FY2023 Q4CAD254,896
CAD254,896
Q4
FY2024 Q1CAD52,555
CAD52,555
Q1
FY2024 Q2CAD213,968
CAD213,968
Q2
FY2024 Q3CAD362,288
CAD362,288
Q3
FY2024 Q4CAD584,237
CAD584,237
Q4
FY2025 Q1CAD226,545
CAD226,545
Q1
FY2025 Q2CAD444,765
CAD444,765
Q2
FY2025 Q3CAD696,519
CAD696,519
Q3
Actual
+CAD334,231 (+92.3%)

Net Income

CAD-438,527
FY2023 Q4CAD-3M
CAD-3M
Q4
FY2024 Q1CAD-662,088
CAD-662,088
Q1
FY2024 Q2CAD-1.3M
CAD-1.3M
Q2
FY2024 Q3CAD-2M
CAD-2M
Q3
FY2024 Q4CAD-2.2M
CAD-2.2M
Q4
FY2025 Q1CAD-645,101
CAD-645,101
Q1
FY2025 Q2CAD-809,010
CAD-809,010
Q2
FY2025 Q3CAD-438,527
CAD-438,527
Q3
Actual
+CAD1.5M (+77.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:CAD1.6M
FY2019
CAD1.6M
FY2020
Actual:CAD2.6M
FY2020
CAD2.6M
FY2021
Actual:CAD2.7M
FY2021
CAD2.7M
FY2022
Actual:CAD1.4M
FY2022
CAD1.4M
FY2023
Actual:CAD254,896
FY2023
CAD254,896
FY2024
Actual:CAD584,237
FY2024
CAD584,237

Analyst Estimates

No forecast data